Ergothioneine
Ergothioneine has been studied in 330 papers since 1964: 7 trials and 24 observational studies in people, 86 in animals, 119 in cells, 75 reviews; 38 in the past year. The newest paper, Nov 19, 2026: “Mitochondrial Dysfunction and Skin Aging: From Fibroblast Senescence to Disrupted ECM Homeostasis”.
Research on it is growing 40% faster than aging research as a whole: 10 papers in the latest year counted
7 new papers in 30 daysSee all 104 papers on ergothioneine
At a glance
Independent labs found the same change in cells, worms or flies, mice and people. 28 independent labs in 16 countries; 8 trials, 3 about aging, 1 with no results posted.
“mean AMH increased from 1.81 ± 0.72 to 2.46 ± 1.54 ng/mL (mean change + 0.65 ng/mL, 95% CI [0.14, 1.17], p = 0.018)”
2 of its findings point the other way.
- 28 independent labs in 16 countries
- 2 findings against
- 8 trials, 3 about aging, 1 with no results posted
- Funders: National Institutes of Health and others
- 10 of 89 findings with company ties
- Human trial6
- Humans11
- Animals18
- Model organisms3
- Cells4
Studies in people
4 studies gave ergothioneine to people and measured what changed.
| What changed | Design | People | Source |
|---|---|---|---|
up: Increases anti-Müllerian hormone+0.65 ng/mL (95% CI [0.14, 1.17]) down: Decreases follicle stimulating hormone-1.33 mIU/mL (95% CI [-2.50, -0.17]) up: Increases estradiol+19.69 pg/mL (95% CI [3.99, 35.38]) | Trialthree consecutive menstrual cycles | 36 peopleWomen35-45 yearsMidlife adults; suboptimal ovarian reserve | BMC women's health, Jun 17, 2026 |
| Randomized trial16 weeks | 100 people51 were females (26 in the EGT group and 25 in the placebo group), and 49 were males (24 in the EGT group and 25 in the placebo group)aged 40–64 yearsJapanese volunteers | Food science & nutrition, Jun 5, 2025 | |
up: Improves cognitive function no change: Has no effect on renal and liver function markers | Randomized trialone year | 19 peopleaged 60 or aboveOlder adults; mild cognitive impairment | Journal of Alzheimer's disease : JAD, Nov 15, 2024 |
| Randomized trial | NPJ science of food, Feb 6, 2024 |
What did studies of ergothioneine find?
67Studies of ergothioneine measured 67 outcomes; the most studied are cognitive function (11 studies), inflammation (10) and oxidative stress and ROS signaling (9).
Cognitive function
upin humans4upin mice4upin reviews4
11 studies
Cognitive function
upin humans4upin mice4upin reviews4
Ergothioneine improves cognitive function in humans (mild cognitive impairment).
Human trialmild cognitive impairmentcapsule25 mg per capsuleone yearn = 19
Ergothioneine improves cognitive function in older adults with mild cognitive impairment.
Reviewin older adults with mild cognitive impairment
Ergothioneine improves cognitive function.
Review
Ergothioneine improves cognitive function in humans.
Reviewup to 25 mg/day
Ergothioneine improves cognitive function.
Review
Ergothioneine improves cognitive function.
Review
Ergothioneine improves cognitive function in mice.
Animals4 ~ 5 mg/kg/daymales
Ergothioneine improves cognitive function in ERGO-deficient mice.
Animalsin ERGO-deficient mice
Ergothioneine improves cognitive function in animal models.
Reviewin animal models
Ergothioneine improves cognitive function in humans.
ReviewERGO-containing food extract tablets
All 12Fewer
Inflammation
downin reviews5downin mice3downin rats2
10 studies
Inflammation
downin reviews5downin mice3downin rats2
Ergothioneine inhibits inflammation.
Review
Ergothioneine decreases inflammation in mice.
Animalsin ovariectomized mice; EGT alone or combined with vitamin K2, vitamin D3 and magnesium L-threonate30 mg/kg/day12 weeksfemales
Ergothioneine decreases inflammation.
Review
Ergothioneine decreases inflammation.
Review
Ergothioneine decreases inflammation in ovariectomized mice.
Animalsin ovariectomized micebone marrow
Ergothioneine decreases inflammation in mice (cystinuria mouse model).
Animalscystinuria mouse modelkidney
Ergothioneine decreases inflammation.
Review
Ergothioneine inhibits inflammation.
Review
Ergothioneine inhibits inflammation in rats (fructose-streptozotocin-induced type-2 diabetic rats).
Animalsfructose-streptozotocin-induced type-2 diabetic ratsoralkidneyseven weeksmales
Ergothioneine decreases inflammation in rats (cytokine insufflated).
Animalscytokine insufflatedlung
Oxidative stress and ROS signaling
downin reviews5downin mice2no changein O. cuniculus1downin rats1
9 studies
Oxidative stress and ROS signaling
downin reviews5downin mice2no changein O. cuniculus1downin rats1
Ergothioneine inhibits oxidative stress and ROS signaling.
Review
Ergothioneine decreases oxidative stress and ROS signaling in ovariectomized mice.
Animalsin ovariectomized miceserum12 weeksfemales
Ergothioneine decreases oxidative stress and ROS signaling in mice.
Animalsin ovariectomized mice; EGT alone or combined with vitamin K2, vitamin D3 and magnesium L-threonate30 mg/kg/day12 weeksfemales
Ergothioneine protects against oxidative stress and ROS signaling.
Review
Ergothioneine decreases oxidative stress and ROS signaling.
Review
Ergothioneine decreases oxidative stress and ROS signaling.
Review
Ergothioneine inhibits oxidative stress and ROS signaling.
Review
Ergothioneine decreases oxidative stress and ROS signaling in low-dose mercury chloride-treated rats.
Animalsin low-dose mercury chloride-treated ratsaorta2 μg/kg30 daysmales
Ergothioneine showed no clear effect on oxidative stress and ROS signaling in O. cuniculus (upon reperfusion following ischemia).
Animalsupon reperfusion following ischemiaheart10(-5) M and 10(-4) M
Lifespan
upin worms4upin flies1upin human cells1upin mice1
6 studies
Lifespan
upin worms4upin flies1upin human cells1upin mice1
Ergothioneine extends lifespan in worms.
Model organisms
Ergothioneine extends lifespan in worms.
Model organisms
Ergothioneine extends lifespan in worms.
Model organisms
Ergothioneine extends lifespan in mice.
Animalsdissolved in drinking water4 ~ 5 mg/kg/daymales
Ergothioneine extends lifespan in human cells (+4 ± 1 PD).
Cells1 μM
Ergothioneine extends lifespan in flies.
Model organisms
Ergothioneine extends lifespan in transgenic Caenorhabditis elegans overexpressing a human Aβ peptide.
Model organismsin transgenic Caenorhabditis elegans overexpressing a human Aβ peptide
Neurodegenerative disease
downin reviews4
4 studies
Neurodegenerative disease
downin reviews4
Ergothioneine prevents neurodegenerative disease (Reviewed cellular, animal, epidemiologic, and human intervention evidence).
ReviewReviewed cellular, animal, epidemiologic, and human intervention evidence
Ergothioneine protects against neurodegenerative disease.
Review
Ergothioneine prevents neurodegenerative disease.
Review
Ergothioneine protects against neurodegenerative disease.
Review
Oxidative phosphorylation
upin mice3
3 studies
Oxidative phosphorylation
upin mice3
Ergothioneine improves oxidative phosphorylation in mice (calcium oxalate nephrolithiasis mouse model).
Animalscalcium oxalate nephrolithiasis mouse modelkidney
Ergothioneine increases oxidative phosphorylation in mice.
Animals
Ergothioneine increases oxidative phosphorylation in mice.
Animals
Exercise performance
upin mice2upin reviews1
3 studies
Exercise performance
upin mice2upin reviews1
Ergothioneine improves exercise performance.
Review
Ergothioneine improves exercise performance in mice.
Animals
Ergothioneine improves exercise performance in mice.
Animals
Healthspan
upin reviews1upin worms1
2 studies
Healthspan
upin reviews1upin worms1
Ergothioneine improves healthspan in preclinical models.
Reviewin preclinical models
Ergothioneine improves healthspan in transgenic Caenorhabditis elegans overexpressing a human Aβ peptide.
Model organismsin transgenic Caenorhabditis elegans overexpressing a human Aβ peptide
Osteoclastogenesis
downin mouse cells2
2 studies
Osteoclastogenesis
downin mouse cells2
Ergothioneine inhibits osteoclastogenesis in vitro.
Cellsin vitro
Ergothioneine inhibits osteoclastogenesis in mouse cells (RANKL-induced in vitro).
CellsRANKL-induced in vitro
Bone loss
downin mice2
2 studies
Bone loss
downin mice2
Ergothioneine decreases bone loss in ovariectomized mice.
Animalsin ovariectomized mice
Ergothioneine decreases bone loss in OVX mice.
Animalsin OVX mice
Serum EV-derived phosphorylated TrkB
upin humans1
1 study
Serum EV-derived phosphorylated TrkB
upin humans1
Ergothioneine increases serum EV-derived phosphorylated TrkB.
Human trial12 weeks
Ergothioneine increases serum EV-derived phosphorylated TrkB in humans.
Human trialtabletsserum extracellular vesicles
Pittsburgh Sleep Quality Index
downin humans1
1 study
Pittsburgh Sleep Quality Index
downin humans1
Ergothioneine decreases Pittsburgh Sleep Quality Index in humans (suboptimal ovarian reserve) (from 6.89 ± 1.82 to 5.50 ± 1.40).
Human trialsuboptimal ovarian reserveoral120 mg/daythree consecutive menstrual cyclesfemalesn = 36
Kupperman Index
downin humans1
1 study
Kupperman Index
downin humans1
Ergothioneine decreases Kupperman Index in humans (suboptimal ovarian reserve) (from 5.42 ± 3.66 to 1.90 ± 2.16).
Human trialsuboptimal ovarian reserveoral120 mg/daythree consecutive menstrual cyclesfemalesn = 36
Estradiol
upin humans1
1 study
Estradiol
upin humans1
Ergothioneine increases estradiol in humans (suboptimal ovarian reserve) (+19.69 pg/mL (95% CI [3.99, 35.38])).
Human trialsuboptimal ovarian reserveoralserum120 mg/daythree consecutive menstrual cyclesfemalesn = 36
Follicle stimulating hormone
downin humans1
1 study
Follicle stimulating hormone
downin humans1
Ergothioneine decreases follicle stimulating hormone in humans (suboptimal ovarian reserve) (-1.33 mIU/mL (95% CI [-2.50, -0.17])).
Human trialsuboptimal ovarian reserveoralserum120 mg/daythree consecutive menstrual cyclesfemalesn = 36
All 67Fewer
What is ergothioneine linked with?
5Studies link ergothioneine with 5 measures, among them Aβ42:40 ratio, preeclampsia and neurodegenerative disease.
Aβ42:40 ratio
upin humans1
1 study
Aβ42:40 ratio
upin humans1
Ergothioneine is associated with Aβ42:40 ratio in the Aβ+ group (r = 0.48, pFDR = 0.05).
Humansin the Aβ+ groupn = 35
Preeclampsia
downin humans1
1 study
Preeclampsia
downin humans1
Ergothioneine lowers the risk of preeclampsia in humans (higher plasma ergothioneine levels).
Reviewhigher plasma ergothioneine levels
Neurodegenerative disease
downin humans1
1 study
Neurodegenerative disease
downin humans1
Ergothioneine lowers the risk of neurodegenerative disease in humans (restoring ET levels in the body).
Reviewrestoring ET levels in the body
Longevity
upin reviews1
1 study
Longevity
upin reviews1
Ergothioneine is associated with longevity.
Review
Blood ergothioneine level
downin humans1
1 study
Blood ergothioneine level
downin humans1
Ergothioneine is associated with blood ergothioneine level in patients.
Reviewin patients
What acts on ergothioneine?
1Studies name SLC22A4 as acting on ergothioneine.
Has ergothioneine been tested in people?
3 of 8 about agingYes: 7 trials and 24 observational studies in people have been published, and 8 trials are registered.
About aging
Every condition in trials
Aging
Phase 4Status unknown1 trial
Aging
No phaseRecruiting1 trial
No phaseRecruiting1 trial
No phaseActive, not recruiting1 trial
No phaseActive, not recruiting1 trial
No phaseRecruiting1 trial
All 8Fewer
Trial sponsors
The First People's Hospital of Kunshan
2 trialsPhase 442 people
1 trial90 people
European Life Science Research Association
1 trial50 people
1 trial28 people
1 trial24 people
Yong Loo Lin School of Medicine, National University of Singapore
1 trial20 people
Midwest Center for Metabolic and Cardiovascular Research
1 trial4 people
Funding
1 grant since 2025Japan Society for the Promotion of Science¥4.6M